ENTA - ENANTA PHARMACEUTICALS INC
IEX Last Trade
4.945
0.055 1.112%
Share volume: 31,911
Last Updated: Mon 13 Jan 2025 08:29:59 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.44%
PREVIOUS CLOSE
CHG
CHG%
$4.89
0.06
1.12%
Summary score
28%
Profitability
18%
Dept financing
11%
Liquidity
75%
Performance
30%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-8.37%
Return on assets
-6.82%
Return on sales
-142.56%
Return on invested capital
-31.82%
Total debt ratio
22.9%
Debt ratio change over timeo
-1.08%
Current Ratio
11.43%
Quick Ratio
12.23%
Cash Position Ratio
9.2%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-15.1%
Return on assets
-8.06%
Return on sales
-185.44%
Return on invested capital
69.42%
Total debt ratio
50.81%
Debt ratio change over timeo
-1%
Current Ratio
6.35%
Quick Ratio
7%
Cash Position Ratio
4.13%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-7.93%
Return on sales
-204.38%
Return on invested capital
0%
Total debt ratio
65.8%
Debt ratio change over time
-1.17%
Current Ratio
5.21%
Quick Ratio
0%
Cash Position Ratio
0.65%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-92.58%
Return on assets
-92.59%
Return on sales
44.89%
Return on invested capital
-42.53%
Total debt ratio
-108.42%
Debt ratio change over time
-1.08%
Current Ratio
-11.82%
Quick Ratio
-13.01%
Cash Position Ratio
-9.73%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ENTA | ABBV | AMGN | VRTX |
|---|---|---|---|---|
| Return on equity | -8.37% | 13.03% | 18.15% | 6.63% |
| Return on assets | -6.82% | 2.28% | 3.22% | 5.84% |
| Return on sales | -142.56% | 27.95% | 31.46% | 43.41% |
| Return on invested capital | -31.82% | 2.07% | 5.53% | 34.89% |
| Profitability | 0% | 45% | 61% | 84% |
| Total debt ratio | 22.9% | 91.02% | 90.77% | 24.67% |
| Debt ratio change over time | -1.08% | 435.59% | 17.23% | -0.06% |
| Dept financing | 6% | 50% | 26% | 7% |
| Current Ratio | 6.35% | 0.8% | 1.33% | 3.64% |
| Quick Ratio | 7% | 0.69% | 0.94% | 3.42% |
| Cash Position Ratio | 4.13% | 0.31% | 0.46% | 2.77% |
| Liquididy | 75% | 4% | 9% | 26% |
| Short-term ratios | ENTA | ABBV | AMGN | VRTX |
|---|---|---|---|---|
| Return on equity | -15.1% | 0% | 0% | 5.91% |
| Return on assets | -8.06% | 1.74% | 2.28% | 4.97% |
| Return on sales | -185.44% | 25.62% | 20.05% | 42.59% |
| Return on invested capital | 69.42% | 0% | 0% | 23.7% |
| Profitability | 25% | 24% | 23% | 84% |
| Total debt ratio | 50.81% | 95.21% | 93.27% | 24.56% |
| Debt ratio change over time | -1% | 0% | 0% | -0.62% |
| Dept financing | 13% | 25% | 49% | 6% |
| Current Ratio | 6.35% | 0.8% | 1.33% | 3.64% |
| Quick Ratio | 7% | 0.69% | 0.94% | 3.42% |
| Cash Position Ratio | 4.13% | 0.31% | 0.46% | 2.77% |
| Liquididy | 75% | 7% | 11% | 43% |